Research Article
Evaluation of AgNORs in Oral Potentially Malignant Lesions
Figure 2
(a), (b), and (c): epithelial lining of inflammatory fibrous hyperplasia; (d), (e), and (f): low risk of malignancy epithelial dysplasia; (g), (h), and (i): high risk of malignancy epithelial dysplasia; (j), (k), and (l): squamous cell carcinoma. (a), (d), (g), and (j): H&E, 100x; (b), (e), (h), and (k): AgNOR, 100x; (c), (f), (i), and (l): AgNOR, 400x.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) |
(j) |
(k) |
(l) |